Literature DB >> 18339487

The effect of changing technique, dose, and PTV margin on therapeutic ratio during prostate radiotherapy.

Shao Hui Huang1, Charles Catton, John Jezioranski, Andrew Bayley, Stuart Rose, Tara Rosewall.   

Abstract

PURPOSE: To quantify the dosimetric and radiobiological changes seen when using intensity-modulated radiation therapy (IMRT) or planning target volume (PTV) margin reduction with consistent planning parameters in a representative sample of localized prostate cancer patients. METHODS AND MATERIALS: Twenty patients were randomly selected from a cohort that received 79.8 Gy using six-field conformal radiotherapy. Using the clinical contours, PTV margin, planning system, and dose constraints, five-field IMRT plans were generated for 79.8, 83.8, and 88.0 Gy. The 88.0-Gy IMRT plan was then reoptimized with a PTV margin reduced to 3 mm. These plans were then compared using various dosimetric and radiobiological endpoints calculated for various alpha/beta.
RESULTS: Intensity-modulated RT resulted in greater conformity to the PTV (p < 0.001). No improvement in mean normal tissue complication probabilities in the rectal wall (NTCPrw) was seen, and the modified therapeutic ratio (TR(mod)) was largely unchanged between six-field conformal and IMRT for the majority of the patients. When IMRT was used to escalate dose, NTCPrw increased by 9% at each 5% prescription increase (p < 0.001). Reducing the posterior PTV margin from 7 mm to 3 mm for an IMRT plan reduced the mean NTCPrw by 12% (p < 0.001) and resulted in a trend toward increased TR(mod)(p = 0.005). Changes in TR(mod) between conformal and IMRT planning or PTV reduction showed large interpatient variability.
CONCLUSIONS: Changing from conformal to IMRT, or from PTV(10-7) to PTV(3), did not produce a uniform interpatient increase in TR(mod)when the CTV contained the prostate alone. Radiobiological benefits of these two methods seem to be dependent on the particular anatomy of individual patients, supporting the use of patient-specific margin, planning, and dose prescription strategies.

Entities:  

Mesh:

Year:  2008        PMID: 18339487     DOI: 10.1016/j.ijrobp.2007.11.055

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  3 in total

1.  Reduction in patient-reported acute morbidity in prostate cancer patients treated with 81-Gy Intensity-modulated radiotherapy using reduced planning target volume margins and electromagnetic tracking: assessing the impact of margin reduction study.

Authors:  Howard M Sandler; Ping-Yu Liu; Rodney L Dunn; David C Khan; Scott E Tropper; Martin G Sanda; Constantine A Mantz
Journal:  Urology       Date:  2010-02-13       Impact factor: 2.649

2.  Schedule for CT image guidance in treating prostate cancer with helical tomotherapy.

Authors:  G Beldjoudi; S Yartsev; G Bauman; J Battista; J Van Dyk
Journal:  Br J Radiol       Date:  2009-06-08       Impact factor: 3.039

3.  An assessment of PTV margin based on actual accumulated dose for prostate cancer radiotherapy.

Authors:  Ning Wen; Akila Kumarasiri; Teamour Nurushev; Jay Burmeister; Lei Xing; Dezhi Liu; Carri Glide-Hurst; Jinkoo Kim; Hualiang Zhong; Benjamin Movsas; Indrin J Chetty
Journal:  Phys Med Biol       Date:  2013-10-18       Impact factor: 3.609

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.